Synektik

Synektik EBIT Margin

The EBIT Margin (Operating Margin) of Synektik (SNT.WA) as of Oct 31, 2026 is 23.05 %. In the previous year, EBIT Margin (Operating Margin) was 17.13 % — a change of 34.51% (higher).

EBIT Margin

23.05 %

YoY

34.51%

Last updated:

EBIT Margin (Operating Margin) of Synektik is 2025 23.05 % . EBIT Margin (Operating Margin) of Synektik was 2024 17.13 % . It decreases by 34.51% higher compared to the previous year.

For Synektik, the operating (EBIT) margin of 23.0% is up versus 8.7% a few years ago.

The Synektik EBIT Margin history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EBIT Margin
Date
EBIT Margin
Jan 1, 2018
11.04 PLN
Jan 1, 2019
9.43 PLN
Jan 1, 2020
9.60 PLN
Jan 1, 2021
8.70 PLN
Jan 1, 2022
4.22 PLN
Jan 1, 2023
15.19 PLN
Jan 1, 2024
17.13 PLN
Jan 1, 2025
23.05 PLN
The Synektik EBIT Margin history
YEAREBIT MarginYoY
23.05 %+34.51%
17.13 %+12.83%
15.19 %+260.00%
4.22 %-51.50%
8.70 %-9.36%
9.60 %+1.72%
9.43 %-14.58%
11.04 %+94.44%
5.68 %+31.93%
4.30 %-732.24%
-0.68 %-109.92%
6.86 %+4,735.87%
0.14 %+4,978.98%
0.00-134.09%
-0.01 %-111.20%
0.07 %+103.23%
0.04 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Synektik Stock analysis

What does Synektik do? Synektik SA generates revenue through its PACS software, which enables diagnostic imaging laboratories to operate efficiently. The company also sells medical equipment and provides services through its imaging equipment services center. Synektik SA partners with Siemens and holds a 100% stake in Miedzynarodowe Centra Medyczne Inwestycje Sp z o o, which it acquired by raising its stake on November 28, 2013. The firm's research laboratory conducts acceptance and specialist tests on X-ray equipment, contributing to its service offerings. The primary buyers of Synektik SA's products include diagnostic imaging laboratories that require PACS software for their operations. Medical equipment is sold to healthcare facilities, while the research laboratory services are utilized by entities needing X-ray equipment testing. The company's partnership with Siemens supports its medical equipment sales and services. Synektik SA's revenue streams are derived from software licensing, medical equipment sales, and specialized testing services. The company's focus on diagnostic imaging solutions and its ownership of Miedzynarodowe Centra Medyczne Inwestycje Sp z o o position it within the medical technology sector, targeting healthcare providers and imaging laboratories. Synektik is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Synektik stock

EBIT Margin (Operating Margin) of Synektik is 23.05 % in 2025.

EBIT Margin (Operating Margin) of Synektik changed from 17.13 % to 23.05 %, representing a 34.51% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of EBIT Margin (Operating Margin) Synektik since 2006 – with annual values, charts, and detailed analysis.

EBIT Margin measures operating profitability as a percentage of revenue. It shows how much profit a company makes from operations before interest and taxes.

A 'good' varies by industry and company stage. On Eulerpool, you can compare EBIT Margin (Operating Margin)'s Synektik with sector peers and the industry average to assess whether it is attractive.

To evaluate EBIT Margin (Operating Margin)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for EBIT Margin (Operating Margin).

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Margins — Synektik

Gross MarginEBIT MarginEBITDA MarginNet MarginFCF MarginR&D / RevenueTax RatePayout RatioPre-Tax MarginOCF MarginSGA/RevenueOpEx/RevenueReinvestment Rate

All Key Metrics — Synektik